Results 231 to 240 of about 57,164 (280)

Eco-friendly spectrofluorimetric determination of remdesivir in the presence of its metabolite in human plasma for therapeutic monitoring in COVID-19 patients. [PDF]

Sci Rep
El-Fattah MHA, Sharaf YA, El-Sayed HM, Hassan SA.   +3 more
europepmc   +1 more source

Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma. [PDF]

BMC Chem
El-Adl SM, El-Shanawani AA, Madbouly EA, Abdelkhalek AS.   +3 more
europepmc   +1 more source

Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir. [PDF]

Infect Dis Rep
Gupta K, O'Brien WJ, Strymish J, Chen A, Linsenmeyer K, Madjarov R, Charness ME.   +6 more
europepmc   +1 more source

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Cell Reports, 2020
A. Pruijssers, Amelia S. George, A. Schäfer, S. Leist, Lisa E. Gralinksi, K. Dinnon, B. Yount, Maria L. Agostini, Laura J. Stevens, J. Chappell, Xiaotao Lu, Tia M. Hughes, K. Gully, David R. Martinez, Ariane J. Brown, Rachel L. Graham, Jason K. Perry, Venice Du Pont, J. Pitts, Bin Ma, D. Babusis, E. Murakami, Joy Y. Feng, J. Bilello, D. Porter, T. Cihlář, R. Baric, M. Denison, T. Sheahan   +28 more
semanticscholar   +1 more source

Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes. [PDF]

RMD Open
Chavatza K, Mastrostamati E, Charalampidis C, Antonogiannaki EM, Grigoropoulos I, Karofylakis E, Gkolemi F, Koromvokis G, Kalara E, Sambatakaki E, Fanouriakis A, Thomas K.   +11 more
europepmc   +1 more source

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1)

, 2020
Amir Qaseem, Jennifer Yost, Itziar Etxeandia‐Ikobaltzeta, George M. Abraham, Janet A. Jokela, Mary Ann Forciea, Matthew C. Miller, Linda L. Humphrey   +7 more
openalex   +2 more sources

A deep learning and molecular modeling approach to repurposing Cangrelor as a potential inhibitor of Nipah virus. [PDF]

Sci Rep
John L, Dcunha L, Ahmed M, Thomas SD, Raju R, Jayanandan A.   +5 more
europepmc   +1 more source

Status of Remdesivir: Not Yet Beyond Question!

, 2020
Saptarshi Chatterjee
openalex   +1 more source

Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain. [PDF]

J Clin Med
Fernández-de-Las-Peñas C, Franco-Moreno A, Ruiz-Ruigómez M, Arrieta-Ortubay E, Ryan-Murua P, Lumbreras-Bermejo C, Del-Valle-Loarte P, Pellicer-Valero OJ, Torres-Macho J, Giordano R, Arendt-Nielsen L.   +10 more
europepmc   +1 more source

Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19. [PDF]

Clin Pharmacokinet
Roberts DM, Liu X, Parker SL, Burke A, Peek J, Carland JE, Murnion B, Seah V, Wallis SC, Sumi CD, Pandey S, Buscher H, Byrne A, Sandaradura I, Bowen D, Holz S, Stewart AG, Hajkowicz KM, Roberts JA.   +18 more
europepmc   +1 more source